In silico design and selection of new tetrahydroisoquinoline-based cd44 antagonist candidates

HIGHLIGHTS

  • who: Angel J. Ruiz-Moreno et al. from the Departamento de Farmacología, Facultad de Medicina, Universidad Nacional Autónoma de Mexico (UNAM) have published the Article: In Silico Design and Selection of New Tetrahydroisoquinoline-Based CD44 Antagonist Candidates, in the Journal: Molecules 2021, 1877 of /2021/
  • what: The authors focused on the compounds showing docking poses matching the crystallized THQ atoms with RMSD and amp;lt; 2 Å . The experiments demonstrate that the compounds Can125 and Can159 bind with high theoretical affinity to the murine and human structures of CD44HAbd and stabilize the conformational dynamics . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?